<DOC>
	<DOCNO>NCT02400203</DOCNO>
	<brief_summary>The objective trial ass effect hemp product consumption , specifically hull hemp seed hemp oil blood fatty acid profile cardiovascular disease risk factor , healthy overweight volunteer 4 week consumption .</brief_summary>
	<brief_title>FREE Living Hulled HEMP Seed Oil Trial</brief_title>
	<detailed_description>The trial 4 week double-blinded , randomize , cross-over design 2 treatment intervention ( hemp control ) period separate 4 week washout period . Thirty metabolically healthy overweight volunteer recruit trial . On day 1 , 27 , 28 treatment period participant ask come Richardson Center Functional Foods Nutraceuticals ( RCFFN ) 12 hour fast blood sample . On day 1 , participant give prepackaged sachet treatment hull seed ( hemp sesame ) salad dressing , contain 30 g/d treatment ( hemp soybean ) oil ( individually package daily container ) also supply . Participants instruct clinical coordinator integrate product ( 2 sachet seed , 1 salad dress ) daily meal avoid dietary source n-3 fatty acid , flax , chia , camelina , krill fish product . Participants give activity monitor wear intervention period . Participants require eat one sachet hull seed morning one evening , consume dress throughout day , 4 week treatment period . Participants ask continue habitual diet , avoid large dietary source n-3 fatty acid , throughout treatment washout period . Participants instruct maintain level physical activity alcohol intake throughout trial period . The trial coordinator contact participant weekly via telephone email monitor treatment adherence answer question concern participant might . Background dietary intake measure day 1 trial use food frequency questionnaire , treatment period 3-day food record complete last week treatment period . Participants ask question intervention include side effect , mood perceive energy level trial coordinator end intervention period .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>Metabolically healthy overweight ( BMI 2535 kg/m2 ) participant age 1865 , Men woman ability give write informed consent comply trial guideline . Pregnancy lactation Smokers ( tobacco product last 6 month ) History cancer , rheumatoid arthritis , chronic illness , cardiovascular problem , liver kidney disease , inflammatory bowel disease , pancreatitis , gallbladder biliary disease , neurological/psychological disease , bleed disorder , experience platelet abnormality , gastrointestinal disorder could interfere fat absorption , serum glucose ≥6.1 mmol/L , serum triglyceride ( TG ) &gt; 4.52 mmol/L , and/or LDL cholesterol ( LDLC ) ≥6.5 mmol/L , hypertension ( systolic blood pressure ≥160 mm Hg diastolic blood pressure ≥100 mm Hg ) , Body mass index ( BMI ; kg/m2 ) ≥35 Consume plan consume anticoagulant , Hypertension lipid lower medication , hypotensive Lipid lower n3 PUFA dietary supplement Reported consumption 2 alcoholic drinks/day history alcoholism drug dependence Reported use experimental medication within 1 month prior start trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>hemp oil ,</keyword>
	<keyword>hemp</keyword>
	<keyword>fatty acid</keyword>
	<keyword>omega-6</keyword>
	<keyword>omega-3</keyword>
	<keyword>blood pressure</keyword>
	<keyword>blood lipid</keyword>
</DOC>